Column Group LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001833486 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value: $707M (100.0% shares, 0.0% debt)

Holdings (5)

— NGM Biopharmaceuticals Inc 43.0%

Value $304M Shares 15,396,116 Est. Cost $30.30 Unrealized —

— RAPT Therapeutics Inc 17.5%

Value $124M Shares 3,885,679 Est. Cost $19.75 Unrealized —

RVMD Revolution Medicines Inc 15.0%

Value $106M Shares 3,347,245 Est. Cost $39.54 Unrealized -11.7%

— Constellation Pharmaceuticals Inc. 12.6%

Value $88.78M Shares 2,626,631 Est. Cost $28.80 Unrealized —

ORIC ORIC Pharmaceuticals Inc. 11.9%

Value $84.35M Shares 4,768,181 Est. Cost $28.69 Unrealized -23.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	NGM Biopharmaceuticals Inc	15,396,116	$304M	43.0%	$30.30	—	COM	62921N105
—	RAPT Therapeutics Inc	3,885,679	$124M	17.5%	$19.75	—	COM	75382E109
RVMD	Revolution Medicines Inc	3,347,245	$106M	15.0%	$39.54	-11.7%	COM	76155X100
—	Constellation Pharmaceuticals Inc.	2,626,631	$88.78M	12.6%	$28.80	—	COM	210373106
ORIC	ORIC Pharmaceuticals Inc.	4,768,181	$84.35M	11.9%	$28.69	-23.6%	COM	68622P109